
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [ASND] Ascendis Pharma A/S
Data updated 2025-May-16 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-May-16 Friday
Open | $155.01 | High | $160.56 +3.58% |
---|---|---|---|
Close | $157.60 | Low | $154.80 -0.14% |
Volume | 501 Thousand 0.79x | Volatility | 3.72% |
Change |
+$0.06
+0.04%
|
Streak | ↑ 2 days +0.25% |
20d SMA | $161.90 -2.7% | 50d SMA | $156.93 +0.4% | 100d SMA | $147.14 +7.1% | 200d SMA | $139.76 +12.8% |
RSI | 49 | MACD | -1.19 | ADX | 13.4 | Stochastic Oscillator | 20.2 21.7 |
CCI | -66.2 | ATR | 8.14 | OBV | 15.1 Million | Chaikin A/D | 24.4 Million |
Market Cap | 8.28 B | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 28.6 | Price/Book (mrq) | EV/Revenue (ttm) | 32 | EV/EBITDA (ttm) | -20.8 | |
% Held by Insiders | 0.76% | % Held by Institutions | 107.83% | Shares Short | 2.94 M | Shares Short (prior month) | 2.97 M |
Short Ratio | 8.77 | Short % of Outstanding | 5.19% | Short % of Float | 5.24% | Shares Short Change (mom) | -1.0% |
Revenue/Share (ttm) | $4.74 | Profit Margin (ttm) | -180.51% | Operating Margin (ttm) | -26.59% | EBITDA (ttm) | -449 M |
Diluted EPS (ttm) | $-9.26 | Current Ratio (mrq) | 3.56 | Return on Assets (ttm) | -29.73% | Return on Equity (ttm) | -818.43% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | 501.40% | Operating Cash Flow (ttm) | -467 M | Free Cash Flow (ttm) | -318 M | |
Choose view type
Daily Performance for Ascendis Pharma A/S. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Ascendis Pharma A/S up to close of 2025-May-16 at $157.60
3-month Performance Benchmarks for Ascendis Pharma A/S:
Related to Ascendis Pharma A/S
Information for Ascendis Pharma A/S
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-16 on Google
SEC Reports : Quarterly reports around 2025-May-16 on SEC Edgar
Compare Ascendis Pharma A/S with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Ascendis Pharma A/S
Industry : Pharmaceuticals industry performance which includes Ascendis Pharma A/S